Cargando…
P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431353/ http://dx.doi.org/10.1097/01.HS9.0000846276.07813.d5 |
| _version_ | 1784780031402180608 |
|---|---|
| author | Diaz-Tejedor, A. San-Segundo, L. Corchete, L. A. González-Méndez, L. Martín-Sánchez, M. Lorenzo-Mohamed, M. González-Rodríguez, M. Cruz-Hernández, M. Sánchez-Blázquez, M. Gutiérrez, N. C. Mateos, M.-V. Garayoa, M. Ocio, E. M. Paíno, T. |
| author_facet | Diaz-Tejedor, A. San-Segundo, L. Corchete, L. A. González-Méndez, L. Martín-Sánchez, M. Lorenzo-Mohamed, M. González-Rodríguez, M. Cruz-Hernández, M. Sánchez-Blázquez, M. Gutiérrez, N. C. Mateos, M.-V. Garayoa, M. Ocio, E. M. Paíno, T. |
| author_sort | Diaz-Tejedor, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313532022-08-31 P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA Diaz-Tejedor, A. San-Segundo, L. Corchete, L. A. González-Méndez, L. Martín-Sánchez, M. Lorenzo-Mohamed, M. González-Rodríguez, M. Cruz-Hernández, M. Sánchez-Blázquez, M. Gutiérrez, N. C. Mateos, M.-V. Garayoa, M. Ocio, E. M. Paíno, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431353/ http://dx.doi.org/10.1097/01.HS9.0000846276.07813.d5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Diaz-Tejedor, A. San-Segundo, L. Corchete, L. A. González-Méndez, L. Martín-Sánchez, M. Lorenzo-Mohamed, M. González-Rodríguez, M. Cruz-Hernández, M. Sánchez-Blázquez, M. Gutiérrez, N. C. Mateos, M.-V. Garayoa, M. Ocio, E. M. Paíno, T. P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA |
| title | P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA |
| title_full | P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA |
| title_fullStr | P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA |
| title_full_unstemmed | P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA |
| title_short | P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA |
| title_sort | p848: tinostamustine (edo-s101), an alkylator and histone deacetylase inhibitor, enhances the efficacy of daratumumab in preclinical models of multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431353/ http://dx.doi.org/10.1097/01.HS9.0000846276.07813.d5 |
| work_keys_str_mv | AT diaztejedora p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT sansegundol p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT corchetela p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT gonzalezmendezl p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT martinsanchezm p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT lorenzomohamedm p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT gonzalezrodriguezm p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT cruzhernandezm p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT sanchezblazquezm p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT gutierreznc p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT mateosmv p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT garayoam p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT ocioem p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma AT painot p848tinostamustineedos101analkylatorandhistonedeacetylaseinhibitorenhancestheefficacyofdaratumumabinpreclinicalmodelsofmultiplemyeloma |